NCT06641921View on ClinicalTrials.gov

Strategy to Prevent Decompensated Heart Failure

NAEnrolling by invitationINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Heart FailureRemote Monitoring
Interventions
DEVICE

Seerlinq haemodynamically-guided heart failure treatment

Heart failure treatment of participants in the Seerlinq intervention arm will be haemodynamically-guided based on the results from the Seerlinq telemedical monitoring system.

Trial Locations (1)

831 01

Seerlinq s.r.o., Bratislava

All Listed Sponsors
collaborator

Premedix Academy

OTHER

lead

Seerlinq s. r. o.

OTHER